Patents by Inventor Joyce Young

Joyce Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230133028
    Abstract: The invention relates to nucleic acid constructs for expression in mice for the reproduction of heavy chain only antibodies and VH domains, transgenic mice, related methods and uses.
    Type: Application
    Filed: October 19, 2022
    Publication date: May 4, 2023
    Applicant: Crescendo Biologics Limited
    Inventors: Yumin Teng, Joyce Young, Brian McGuinness, Mike Romanos, Marianne Brueggemann
  • Patent number: 11547099
    Abstract: The invention relates to nucleic acid constructs for expression in mice for the production of heavy chain only antibodies and VH domains, transgenic mice, related methods and uses.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: January 10, 2023
    Assignee: Crescendo Biologies Limited
    Inventors: Yumin Teng, Joyce Young, Brian McGuinness, Mike Romanos, Marianne Brueggemann
  • Publication number: 20180362666
    Abstract: The invention relates to nucleic acid constructs for expression in mice for the production of heavy chain only antibodies and VH domains, transgenic mice, related methods and uses.
    Type: Application
    Filed: October 22, 2014
    Publication date: December 20, 2018
    Applicant: Crescendo Biologics Limited
    Inventors: Yumin Teng, Joyce Young, Brian McGuinness, Mike Romanos, Marianne Brueggemann
  • Publication number: 20180215829
    Abstract: Binding molecules that bind specifically to IL-17RA. The binding molecules are useful in the treatment of disease, for example psoriasis.
    Type: Application
    Filed: January 12, 2016
    Publication date: August 2, 2018
    Inventors: Bryan EDWARDS, Ulla LASHMAR, Brian MCGUINNESS, Mike ROMANOS, Thomas SANDAL, Joyce Young
  • Publication number: 20060093685
    Abstract: Liquid dietary supplements include vitamins, macro minerals, trace minerals, high Oxygen Radical Absorption Capacity (ORAC) compounds, and optionally fulvates. Despite the tendency of minerals in such a liquid mineral and vitamin supplement to precipitate and for the ingredients to quickly degrade, particularly at high ORAC values and low pH, embodiments of the invention stay in solution have a desired shelf life without degrading. In part, this is achieved through the use of the natural preservative momordica, carefully formulated amounts of the various ingredients, and high-tech processing.
    Type: Application
    Filed: July 1, 2005
    Publication date: May 4, 2006
    Inventors: Thomas Mower, Marlin Harmon, James Bawden, Daniel Banks, Joyce Young